Prevalência de transtornos psiquiátricos em pacientes em hemodiálise no estado da Bahia

Moura, José Andrade; Souza, Carlos Alfredo Marcílio de; Oliveira, Irismar Reis de; Miranda, Roberta Oliveira

doi:10.1590/s0047-20852006000300001

Cited by 9 publications

(4 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Participants (3 studies) from AFR [30,58,70]; 4,295 (14 studies) from EUR [31,33,34,36,39,43,56,61,66,68,75,78,80,82]; 3,962 (17 studies) from AMR [22,23,24,25,26,29,32,35,38,45,53,55,62,65,67,69,77]; 679 (7 studies) from EMR [40,49,51,60,64,74,81]; 846 (7 studies) from SEAR [28,47,50,59,71,73,79], and 69,660 (13 studies) from the WPR. [27,37,41,42,44,46,48,52,54,57,63,72,76] Figure 2 shows the geographical distribution of the continents of the included studies.…”

Section: Resultsmentioning

confidence: 99%

“…The clinical diagnostic criteria included those of the DSM (20 studies, 2,028 participants) [23,26,27,28,32,34,35,42,46,49,56,60,66,67,70,72,73,74,76,78] ICD (5 studies, 69,954 participants) [25,37,47,71,79] SCID (15 studies, 1,435 participants)[22,33,39,40,43,48,51,53,54,56,57,59,61,65,82], and MINI (21 studies, 6,274 participants). [24,29,30,31,36,38,41,44,45,50,52,55,58,62,64,68,69,75,77,80,81] The sample size of the component studies ranged from 20 [70] to 67,866 [37] patients, with the proportion of women ranging from 0% [25] to 68% [74]. The mean age of the participants ranged from 11.0 years [60] to 76.3 years [77].…”

Section: Resultsmentioning

confidence: 99%

“…Patients and/or the public were not involved in the design, conduct, reporting, or dissemination plans of this research. participants (3 studies) from AFR [30,58,70]; 4,295 (14 studies) from EUR [31,33,34,36,39,43,56,61,66,68,75,78,80,82]; 3,962 (17 studies) from AMR [22,23,24,25,26,29,32,35,38,45,53,55,62,65,67,69,77]; 679 (7 studies) from EMR [40,49,51,60,64,74,81]; 846 (7 studies) from SEAR [28,47,50,59,71,73,79], and 69,660 (13 studies) from the WPR. [27,…”

Section: Patient and Public Involvementmentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

Global Prevalence of Depression in Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Adejumo,

Edeki,

Dapo

et al. 2023

Preprint

View full text Add to dashboard Cite

BackgroundChronic kidney disease (CKD) is commonly associated with psychosocial problems, especially depression, contributing to poor overall outcomes in CKD patients. Depression has not been given adequate priority in the management of CKD despite its significant adverse impact.ObjectivesThis systematic review and meta-analysis determined the pooled prevalence of clinical depression in the global CKD population and sub-populations.DesignA systematic search of PubMed, African Journals Online (AJOL), and EMBASE was undertaken to identify published articles with relevant data between 1989 and 2022. The pooled prevalence of clinical depression in the global CKD population was determined using random effects meta-analytic techniques.ParticipantsGlobal adult and paediatric CKD populationResultsEligible Sixty-one articles were included in this review, comprising 79,691 CKD patients from 26 countries. The participants’ mean age ranged from 11.0 to 76.3 years. Most (68.9%) of the studies had medium methodological quality. The overall pooled prevalence of depression was 27.6% (95% CI: 23.9–31.5%). Studies using Diagnostic Statistical Manual (DSM), International Classification of Disease, Mini-International Neuropsychiatric Interview and Structured Clinical Interview for DSM disorder returned a pooled prevalence of 31.7%, 39.6%, 23.3%, 25.1%, respectively; p=0.09. There was significant difference in the pooled prevalence of CKD across the various continents; p=0.01.The prevalence of depression was higher among patients on chronic haemodialysis compared to those in pre-dialysis (31.1% versus 18.9%; p=0.02), and among those on hemodialysis compared to peritoneal dialysis (31.9% versus 20.4%; p=0.03). There was no significant difference between adults and children (28.0% versus 15.9%, p=0.17).ConclusionDepression is a common disorder in patients with CKD. The findings of this study have brought to the fore the need for clinicians to make deliberate efforts to evaluate CKD patients for depression, especially those with advanced stages of the disease.The study protocol was registered with PROSPERO (CRD42022382708)Strengths and LimitationsThe pooled prevalence of depression in this study correctly represents the magnitude of the depression in the CKD population because it included only studies where depression was diagnosed clinically.This review involved the global population of both adult and paediatric patients with pre-dialysis and dialytic kidney disease.Only a few studies in this review determined the prevalence of depression in the early stages of CKD.Studies reporting depression prevalence among kidney transplant patients were not included in this review, and the number of studies in the paediatric population was limited.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Patient and Public Involvementmentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Global Prevalence of Depression in Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Adejumo,

Edeki,

Dapo

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

Global prevalence of depression in chronic kidney disease: a systematic review and meta-analysis

Adejumo,

Edeki,

Sunday Oyedepo

et al. 2024

J Nephrol

View full text Add to dashboard Cite

Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies

Palmer

Vecchio

Craig

et al. 2013

Kidney International

681

495

View full text Add to dashboard Cite

Prevalence estimates of depression in chronic kidney disease (CKD) vary widely in existing studies. We conducted a systematic review and meta-analysis of observational studies to summarize the point prevalence of depressive symptoms in adults with CKD. We searched MEDLINE and Embase (through January 2012). Random-effects meta-analysis was used to estimate the prevalence of depressive symptoms. We also limited the analyses to studies using clinical interview and prespecified criteria for diagnosis. We included 249 populations (55,982 participants). Estimated prevalence of depression varied by stage of CKD and the tools used for diagnosis. Prevalence of interview-based depression in CKD stage 5D was 22.8% (confidence interval (CI), 18.6-27.6), but estimates were somewhat less precise for CKD stages 1-5 (21.4% (CI, 11.1-37.2)) and for kidney transplant recipients (25.7% (12.8-44.9)). Using self- or clinician-administered rating scales, the prevalence of depressive symptoms for CKD stage 5D was higher (39.3% (CI, 36.8-42.0)) relative to CKD stages 1-5 (26.5% (CI, 18.5-36.5)) and transplant recipients (26.6% (CI, 20.9-33.1)) and suggested that self-report scales may overestimate the presence of depression, particularly in the dialysis setting. Thus, interview-defined depression affects approximately one-quarter of adults with CKD. Given the potential prevalence of depression in the setting of CKD, randomized trials to evaluate effects of interventions for depression on patient-centered outcomes are needed.

show abstract

Prevalência de transtornos psiquiátricos em pacientes em hemodiálise no estado da Bahia

Cited by 9 publications

References 10 publications

Global Prevalence of Depression in Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Global Prevalence of Depression in Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Global prevalence of depression in chronic kidney disease: a systematic review and meta-analysis

Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies

Contact Info

Product

Resources

About